Clinical Trial Update: Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane [Phase 2]

View source ↗

Summary

This document reports a Phase 2 trial evaluating neoadjuvant endocrine therapy with exemestane for breast cancer, and notes the study status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromasin (exemestane)

Snippet

Sponsor: Austrian Breast & Colorectal Cancer Study Group | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED